Cetera Investment Advisers Purchases 1,763 Shares of U.S. Physical Therapy, Inc. (NYSE:USPH)

Cetera Investment Advisers grew its position in U.S. Physical Therapy, Inc. (NYSE:USPH) by 31.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 7,458 shares of the company’s stock after purchasing an additional 1,763 shares during the period. Cetera Investment Advisers’ holdings in U.S. Physical Therapy were worth $662,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently modified their holdings of USPH. HighTower Advisors LLC lifted its stake in U.S. Physical Therapy by 2.5% in the 4th quarter. HighTower Advisors LLC now owns 4,833 shares of the company’s stock valued at $429,000 after acquiring an additional 119 shares in the last quarter. CBIZ Investment Advisory Services LLC raised its holdings in shares of U.S. Physical Therapy by 59.8% in the fourth quarter. CBIZ Investment Advisory Services LLC now owns 326 shares of the company’s stock valued at $29,000 after purchasing an additional 122 shares during the last quarter. Aquatic Capital Management LLC lifted its position in shares of U.S. Physical Therapy by 18.0% in the fourth quarter. Aquatic Capital Management LLC now owns 1,298 shares of the company’s stock worth $115,000 after purchasing an additional 198 shares in the last quarter. Norden Group LLC lifted its position in shares of U.S. Physical Therapy by 4.8% in the fourth quarter. Norden Group LLC now owns 5,139 shares of the company’s stock worth $456,000 after purchasing an additional 235 shares in the last quarter. Finally, Illinois Municipal Retirement Fund boosted its holdings in U.S. Physical Therapy by 3.6% during the fourth quarter. Illinois Municipal Retirement Fund now owns 8,351 shares of the company’s stock worth $741,000 after purchasing an additional 292 shares during the last quarter.

Wall Street Analyst Weigh In

USPH has been the topic of several recent research reports. William Blair reiterated a “market perform” rating on shares of U.S. Physical Therapy in a research note on Thursday, February 27th. Wall Street Zen raised U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research report on Thursday, May 8th. JPMorgan Chase & Co. dropped their target price on U.S. Physical Therapy from $120.00 to $110.00 and set an “overweight” rating on the stock in a report on Wednesday, March 19th. JMP Securities restated a “market outperform” rating and issued a $113.00 price target on shares of U.S. Physical Therapy in a research note on Tuesday, April 22nd. Finally, Barrington Research lowered their price target on U.S. Physical Therapy from $108.00 to $98.00 and set an “outperform” rating on the stock in a research report on Friday, February 28th. Two equities research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $109.00.

Insider Buying and Selling at U.S. Physical Therapy

In other news, COO Graham D. Reeve sold 1,730 shares of the company’s stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $82.11, for a total value of $142,050.30. Following the transaction, the chief operating officer now owns 7,168 shares of the company’s stock, valued at approximately $588,564.48. This represents a 19.44% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 2.00% of the company’s stock.

U.S. Physical Therapy Stock Down 1.9%

Shares of USPH stock opened at $73.96 on Monday. U.S. Physical Therapy, Inc. has a 52-week low of $62.77 and a 52-week high of $102.89. The stock has a market cap of $1.12 billion, a price-to-earnings ratio of 78.68, a PEG ratio of 3.54 and a beta of 1.44. The firm’s 50-day moving average is $71.89 and its 200-day moving average is $83.20. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.78 and a current ratio of 1.78.

U.S. Physical Therapy (NYSE:USPH) last announced its quarterly earnings results on Wednesday, May 7th. The company reported $0.48 earnings per share for the quarter, topping analysts’ consensus estimates of $0.46 by $0.02. U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. The firm had revenue of $183.79 million for the quarter, compared to the consensus estimate of $176.78 million. During the same quarter in the previous year, the business earned $0.51 earnings per share. The business’s revenue was up 18.0% compared to the same quarter last year. Sell-side analysts predict that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current year.

U.S. Physical Therapy Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, June 13th. Shareholders of record on Friday, May 23rd will be issued a $0.45 dividend. The ex-dividend date of this dividend is Friday, May 23rd. This represents a $1.80 annualized dividend and a dividend yield of 2.43%. U.S. Physical Therapy’s dividend payout ratio is currently 82.57%.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.